Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cipla Ltd.
NSE: CIPLA
|
BSE: 500087
|
ISIN: INE059A01026
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
1463.0500
47.45
(
3.35
%)
NSE
Apr 11, 2025
15:31 PM
Volume:
2.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cipla Ltd.
04 Dec 2024
US FDA Approval
1463.05
3.35%
CIPLA LTD
Buy:
Cipla Ltd.
by
Geojit BNP Paribas
Target: 1695 | Upside : 15.9%
Target
Geojit BNP Paribas
Cipla Ltd. is trading
below its 100 day SMA
of 1467.3
More from Cipla Ltd.
Recommended
Five Interesting Stocks Today - April 11, 2025
The Baseline |
11 Apr 2025
Market closes higher, Aurobindo Pharma's US plant gets Form 483 with 11 FDA observations
Trendlyne Marketwatch |
11 Apr 2025
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
|
20 May 2022